Rapid in vivo detection of isoniazid-sensitive Mycobacterium tuberculosis by breath test

[1]  W. Bishai,et al.  In Vitro and In Vivo Studies of a Rapid and Selective Breath Test for Tuberculosis Based upon Mycobacterial CO Dehydrogenase , 2014, mBio.

[2]  Abhijit Maity,et al.  Residual gas analyzer mass spectrometry for human breath analysis: a new tool for the non-invasive diagnosis of Helicobacter pylori infection , 2014, Journal of breath research.

[3]  H. Gresham,et al.  Nox2 Modification of LDL Is Essential for Optimal Apolipoprotein B-mediated Control of agr Type III Staphylococcus aureus Quorum-sensing , 2013, PLoS pathogens.

[4]  Stanislas Leibler,et al.  Dynamic Persistence of Antibiotic-Stressed Mycobacteria , 2013, Science.

[5]  T. Kirikae,et al.  A Novel Mechanism of Growth Phase-dependent Tolerance to Isoniazid in Mycobacteria* , 2012, The Journal of Biological Chemistry.

[6]  Raymund B. Dantes,et al.  Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis , 2012, PloS one.

[7]  John L. Johnson,et al.  A Novel Metabolite of Antituberculosis Therapy Demonstrates Host Activation of Isoniazid and Formation of the Isoniazid-NAD+ Adduct , 2012, Antimicrobial Agents and Chemotherapy.

[8]  C. Locht,et al.  Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors. , 2011, Journal of medicinal chemistry.

[9]  Nicholas A. Be,et al.  Strain-dependent CNS dissemination in guinea pigs after Mycobacterium tuberculosis aerosol challenge. , 2011, Tuberculosis.

[10]  W. Bishai,et al.  13[C]-Urea Breath Test as a Novel Point-of-Care Biomarker for Tuberculosis Treatment and Diagnosis , 2010, PloS one.

[11]  C. Vilchèze,et al.  Mycobacterium tuberculosis Dihydrofolate Reductase Is Not a Target Relevant to the Antitubercular Activity of Isoniazid , 2010, Antimicrobial Agents and Chemotherapy.

[12]  W. Bishai,et al.  The Impact of Mouse Passaging of Mycobacterium tuberculosis Strains prior to Virulence Testing in the Mouse and Guinea Pig Aerosol Models , 2010, PloS one.

[13]  M. Pai.  Spectrum of latent tuberculosis — existing tests cannot resolve the underlying phenotypes , 2010, Nature Reviews Microbiology.

[14]  Sujata Sharma,et al.  Mode of Binding of the Tuberculosis Prodrug Isoniazid to Heme Peroxidases , 2009, The Journal of Biological Chemistry.

[15]  J. Flynn,et al.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies , 2009, Nature Reviews Microbiology.

[16]  Zheng Ouyang,et al.  Handheld miniature ion trap mass spectrometers. , 2009, Analytical chemistry.

[17]  Pilho Kim,et al.  PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release , 2008, Science.

[18]  E. Pohl,et al.  The Metal-Dependent Regulators FurA and FurB from Mycobacterium Tuberculosis , 2008, International journal of molecular sciences.

[19]  Robert Horsburgh,et al.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.

[20]  M. Matsumoto,et al.  OPC-67683, a Nitro-Dihydro-Imidazooxazole Derivative with Promising Action against Tuberculosis In Vitro and In Mice , 2006, PLoS medicine.

[21]  J. Norton,et al.  Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Locht,et al.  Structure of EthR in a ligand bound conformation reveals therapeutic perspectives against tuberculosis. , 2004, Molecular cell.

[23]  J. T. Crawford,et al.  ethA, inhA, and katG Loci of Ethionamide-Resistant Clinical Mycobacterium tuberculosis Isolates , 2003, Antimicrobial Agents and Chemotherapy.

[24]  S. Cole,et al.  Effect of katG Mutations on the Virulence of Mycobacterium tuberculosis and the Implication for Transmission in Humans , 2002, Infection and Immunity.

[25]  V. Deretic,et al.  Mapping of Mycobacterium tuberculosis katG Promoters and Their Differential Expression in Infected Macrophages , 2001, Journal of bacteriology.

[26]  V. Deretic,et al.  Mycobacterial FurA is a negative regulator of catalase–peroxidase gene katG , 2001, Molecular microbiology.

[27]  C. Locht,et al.  Activation of the pro-drug ethionamide is regulated in mycobacteria. , 2000, The Journal of biological chemistry.

[28]  K. Miki,et al.  [Effects of INH (Isoniazid) inhalation in patients with endobronchial tuberculosis (EBTB)]. , 1999, Kekkaku : [Tuberculosis].

[29]  D. Rouse,et al.  Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. , 1998, The Journal of infectious diseases.

[30]  J. Sacchettini,et al.  Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. , 1998, Science.

[31]  Ying Zhang,et al.  Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus , 1996, Nature Medicine.

[32]  M. Mckee,et al.  ABSOLUTE RATE CONSTANTS IN THE CONCERTED REDUCTION OF OLEFINS BY DIAZENE , 1995 .

[33]  T. Wilson,et al.  Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis , 1995, Molecular microbiology.

[34]  S. Cole,et al.  Missense mutations in the catalase‐peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis , 1995, Molecular microbiology.

[35]  S. Dhandayuthapani,et al.  Gene expression in mycobacteria: transcriptional fusions based on xylE and analysis of the promoter region of the response regulator mtrA from Mycobacterium tuberculosis , 1994, Molecular microbiology.

[36]  D. Martin,et al.  Gene cluster controlling conversion to alginate-overproducing phenotype in Pseudomonas aeruginosa: functional analysis in a heterologous host and role in the instability of mucoidy , 1994, Journal of bacteriology.

[37]  D. Stanbury,et al.  Direct Detection of Aqueous Diazene: Its UV Spectrum and Concerted Dismutation , 1994 .

[38]  S. Cole,et al.  The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis , 1992, Nature.

[39]  R. Taylor,et al.  Reduction with Diimide , 1992 .

[40]  D. Mitchison,et al.  The curious characteristics of pyrazinamide: a review. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.